Cypress Returns Fire Against Glaxo Over Zantac
A generic drug maker has opposed Glaxo Group Ltd.'s patent claims over ulcer drug Zantac, claiming that the patent is invalid and noninfringed....To view the full article, register now.
Already a subscriber? Click here to view full article